These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18469483)

  • 21. Effect of experimental hypo- and hyperthyroidism on serum adiponectin.
    Aragão CN; Souza LL; Cabanelas A; Oliveira KJ; Pazos-Moura CC
    Metabolism; 2007 Jan; 56(1):6-11. PubMed ID: 17161219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.
    Rittmaster RS; Zwicker H; Abbott EC; Douglas R; Givner ML; Gupta MK; Lehmann L; Reddy S; Salisbury SR; Shlossberg AH; Tan MH; York SE
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3283-8. PubMed ID: 8784084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma levels of resistin and ghrelin before and after treatment in patients with hyperthyroidism.
    El Gawad SS; El Kenawy F; Mousa AA; Omar AA
    Endocr Pract; 2012; 18(3):376-81. PubMed ID: 21742599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperthyroidism is characterized by both increased sympathetic and decreased vagal modulation of heart rate: evidence from spectral analysis of heart rate variability.
    Chen JL; Chiu HW; Tseng YJ; Chu WC
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):611-6. PubMed ID: 16712661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of thyrotropin receptor antibodies in the development of hyperthyroidism: follow-up studies on nine patients with Graves' disease.
    Kasagi K; Tamai H; Morita T; Hidaka A; Hatabu H; Misaki T; Iida Y; Ishihara T; Ikekubo K; Kuma K
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1189-94. PubMed ID: 2566620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship of psychological factors to the prognosis of hyperthyroidism in antithyroid drug-treated patients with Graves' disease.
    Fukao A; Takamatsu J; Murakami Y; Sakane S; Miyauchi A; Kuma K; Hayashi S; Hanafusa T
    Clin Endocrinol (Oxf); 2003 May; 58(5):550-5. PubMed ID: 12699435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum levels of insulin-like growth factor 1 are negatively associated with log transformation of thyroid-stimulating hormone in Graves' disease patients with hyperthyroidism or subjects with euthyroidism: A prospective observational study.
    Tseng FY; Chen YT; Chi YC; Chen PL; Yang WS
    Medicine (Baltimore); 2019 Mar; 98(11):e14862. PubMed ID: 30882687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperthyroidism caused by a pituitary thyrotrophin-secreting tumour with excessive secretion of thyrotrophin-releasing hormone and subsequently followed by Graves' disease in a middle-aged woman.
    Kamoi K; Mitsuma T; Sato H; Yokoyama M; Washiyama K; Tanaka R; Arai O; Takasu N; Yamada T
    Acta Endocrinol (Copenh); 1985 Nov; 110(3):373-82. PubMed ID: 3934894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum cytokines in thyrotoxicosis.
    Siddiqi A; Monson JP; Wood DF; Besser GM; Burrin JM
    J Clin Endocrinol Metab; 1999 Feb; 84(2):435-9. PubMed ID: 10022397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.
    Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T
    N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of thyrotoxicosis with lithium carbonate.
    Lazarus JH; Richards AR; Addison GM; Owen GM
    Lancet; 1974 Nov; 2(7890):1160-3. PubMed ID: 4139588
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of colestipol in the treatment of hyperthyroidism.
    Hagag P; Nissenbaum H; Weiss M
    J Endocrinol Invest; 1998 Dec; 21(11):725-31. PubMed ID: 9972670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of iodide on serum thyroid hormone levels in normal persons, in hyperthyroid patients, and in hypothyroid patients on thyroxine replacement.
    Philippou G; Koutras DA; Piperingos G; Souvatzoglou A; Moulopoulos SD
    Clin Endocrinol (Oxf); 1992 Jun; 36(6):573-8. PubMed ID: 1424182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pituitary-thyroid regulation in euthyroid patients with Graves' disease previously treated with antithyroid drugs.
    Buerklin EM; Schimmel M; Utiger RD
    J Clin Endocrinol Metab; 1976 Aug; 43(2):419-27. PubMed ID: 59733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications.
    Bayer MF; Kriss JP; McDougall IR
    J Nucl Med; 1985 Nov; 26(11):1248-56. PubMed ID: 3840528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of thyroid-stimulating hormone, total thyroxine, and free thyroxine concentrations in hyperthyroid cats receiving methimazole treatment.
    Aldridge C; Behrend EN; Martin LG; Refsal K; Kemppainen RJ; Lee HP; Chciuk K
    J Vet Intern Med; 2015; 29(3):862-8. PubMed ID: 25832129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association Between Serum Levels of Adipocyte Fatty Acid-binding Protein and Free Thyroxine.
    Tseng FY; Chen PL; Chen YT; Chi YC; Shih SR; Wang CY; Chen CL; Yang WS
    Medicine (Baltimore); 2015 Oct; 94(41):e1798. PubMed ID: 26469926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of serum thyrotropin with thyroxine in patients with Graves' disease: effects on recurrence of hyperthyroidism and thyroid volume.
    Pfeilschifter J; Ziegler R
    Eur J Endocrinol; 1997 Jan; 136(1):81-6. PubMed ID: 9037131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of 1 alpha-hydroxyvitamin D3 on serum levels of thyroid hormones in hyperthyroid patients with untreated Graves' disease.
    Kawakami-Tani T; Fukawa E; Tanaka H; Abe Y; Makino I
    Metabolism; 1997 Oct; 46(10):1184-8. PubMed ID: 9322804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hyperthyroidism].
    Bürgi U; Maurer P
    Schweiz Rundsch Med Prax; 1994 Jan; 83(3):61-4. PubMed ID: 7507596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.